These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3890111)

  • 41. Anti-trichomonad IgA antibodies in trichomoniasis before and after treatment.
    Sharma P; Malla N; Gupta I; Ganguly NK; Mahajan RC
    Folia Microbiol (Praha); 1991; 36(3):302-4. PubMed ID: 1841864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigen-specific proliferation responses of peripheral blood lymphocytes to Trichomonas vaginalis antigen in patients with Trichomonas vaginitis.
    Yano A; Aosai F; Yui K; Kojima S; Kawana T
    J Clin Microbiol; 1983 Feb; 17(2):175-80. PubMed ID: 6601112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A preliminary study of antibodies against Trichomonas vaginalis infection using the I.F.A.T.
    Salem SA; Azab ME; Safer EH; Aboul-Magd LA
    J Egypt Soc Parasitol; 1981 Jun; 11(1):201-6. PubMed ID: 7028881
    [No Abstract]   [Full Text] [Related]  

  • 44. Trichomonas vaginalis: alternative pathway activation of complement.
    Holbrook TW; Boackle RJ; Vesely J; Parker BW
    Trans R Soc Trop Med Hyg; 1982; 76(4):473-5. PubMed ID: 6763788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlation between the concentration of secretory antibodies and the distribution of vaginal flora].
    Voiculescu C; Rogoz S; Marx M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(4):335-40. PubMed ID: 3327137
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibody in sera of patients infected with Trichomonas vaginalis is to trichomonad proteinases.
    Alderete JF; Newton E; Dennis C; Neale KA
    Genitourin Med; 1991 Aug; 67(4):331-4. PubMed ID: 1916796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of the usefulness of indirect immunofluorescence technic for serodiagnosis of trichomonas vaginitis].
    Laudańska H; Małyszko E; Szarmach H; Niczyporuk W
    Przegl Dermatol; 1980; 67(2):187-92. PubMed ID: 6996038
    [No Abstract]   [Full Text] [Related]  

  • 48. Identification of Trichomonas vaginalis alpha-actinin as the most common immunogen recognized by sera of women exposed to the parasite.
    Addis MF; Rappelli P; Pinto De Andrade AM; Rita FM; Colombo MM; Cappuccinelli P; Fiori PL
    J Infect Dis; 1999 Nov; 180(5):1727-30. PubMed ID: 10515842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of direct microscopic examination, acridine orange staining and culture methods for studies of Trichomonas vaginalis in vaginal discharge specimens].
    Cevahir N; Kaleli I; Kaleli B
    Mikrobiyol Bul; 2002; 36(3-4):329-35. PubMed ID: 12838668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [IgA-antibodies in vaginal secretions following vaccination with Solco Trichovac].
    Milovanović R; Grcić R; Stojković L
    Gynakol Rundsch; 1982; 22 Suppl 2():46-8. PubMed ID: 7166257
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative investigations on antigenic properties of T. vaginalis and Toxoplasma gondii.
    Jŏgiste A; Teras J; Lahhonina G
    Wiad Parazytol; 1973; 19(3):395-7. PubMed ID: 4542495
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparative study of epitopes recognized by two monoclonal antibodies that protects mice against Trichomonas vaginalis challenge.
    Hernández H; Marcet R; Figueredo M; Garrido N; Sarracent J
    Exp Parasitol; 2008 Apr; 118(4):583-6. PubMed ID: 18031741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trichomonas vaginalis infection activates cells through toll-like receptor 4.
    Zariffard MR; Harwani S; Novak RM; Graham PJ; Ji X; Spear GT
    Clin Immunol; 2004 Apr; 111(1):103-7. PubMed ID: 15093558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women.
    Pavic R; Stojković L
    Gynakol Rundsch; 1983; 23 Suppl 2():27-38. PubMed ID: 6629132
    [No Abstract]   [Full Text] [Related]  

  • 55. [Research progress on the detection methods of trichomoniasis vaginalis].
    Xie H; Zhen CN; Wang YJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):179-81. PubMed ID: 15597718
    [No Abstract]   [Full Text] [Related]  

  • 56. Humoral and T cell-mediated immune response against trichomoniasis.
    Nemati M; Malla N; Yadav M; Khorramdelazad H; Jafarzadeh A
    Parasite Immunol; 2018 Mar; 40(3):. PubMed ID: 29266263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trichomonas vaginalis: in vitro phagocytosis of lactobacilli, vaginal epithelial cells, leukocytes, and erythrocytes.
    Rendón-Maldonado JG; Espinosa-Cantellano M; González-Robles A; Martínez-Palomo A
    Exp Parasitol; 1998 Jun; 89(2):241-50. PubMed ID: 9635448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgA antibodies in the vaginal secretion after vaccination with SolcoTrichovac.
    Milovanović R; Grcić R; Stojković L
    Gynakol Rundsch; 1983; 23 Suppl 2():46-9. PubMed ID: 6629135
    [No Abstract]   [Full Text] [Related]  

  • 59. Systemic immune response to Trichomonas vaginalis infection during pregnancy.
    Anderson BL; Cosentino LA; Simhan HN; Hillier SL
    Sex Transm Dis; 2007 Jun; 34(6):392-6. PubMed ID: 17028509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function.
    Singh BN; Hayes GR; Lucas JJ; Sommer U; Viseux N; Mirgorodskaya E; Trifonova RT; Sassi RR; Costello CE; Fichorova RN
    Glycoconj J; 2009 Jan; 26(1):3-17. PubMed ID: 18604640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.